CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well CCI-779 works in treating patients with stage IIIB
non small cell lung cancer (with pleural effusion) or stage IV non-small cell lung cancer.
Drugs used in chemotherapy, such as CCI-779, work in different ways to stop tumor cells from
dividing so they stop growing or die. CCI-779 may also stop the growth of tumor cells by
blocking the enzymes necessary for their growth.